Mondello P - Search Results

1

Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.

Mondello P, Derenzini E, Asgari Z, Philip J, Brea EJ, Seshan V, Hendrickson RC, de Stanchina E, Scheinberg DA, Younes A. Mondello P, et al. Oncotarget. 2017 Feb 21;8(8):14017-14028. doi: 10.18632/oncotarget.14876. Oncotarget. 2017. PMID: 28147336 Free PMC article.

2

90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment.

Mondello P, Pitini V, Arrigo C, Derenzini E, Mian M. Mondello P, et al. Anticancer Res. 2014 Sep;34(9):5121-5. Anticancer Res. 2014. PMID: 25202102 Free article.

3

Emerging drugs for diffuse large B-cell lymphoma.

Mondello P, Younes A. Mondello P, et al. Expert Rev Anticancer Ther. 2015 Apr;15(4):439-51. doi: 10.1586/14737140.2015.1009042. Epub 2015 Feb 5. Expert Rev Anticancer Ther. 2015. PMID: 25652253 Review.

4

90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr.

Mondello P, Cuzzocrea S, Navarra M, Mian M. Mondello P, et al. Oncotarget. 2016 Feb 16;7(7):7597-609. doi: 10.18632/oncotarget.6531. Oncotarget. 2016. PMID: 26657116 Free PMC article. Review.

5

Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent.

Mondello P, Pitini V, Barresi V, Brea EJ, Di Mirto C, Arrigo C, Cuzzocrea S, Mian M. Mondello P, et al. Exp Hematol Oncol. 2016 Jan 6;5:1. doi: 10.1186/s40164-015-0030-1. eCollection 2015. Exp Hematol Oncol. 2016. PMID: 26740908 Free PMC article.

6

Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.

Brea EJ, Oh CY, Manchado E, Budhu S, Gejman RS, Mo G, Mondello P, Han JE, Jarvis CA, Ulmert D, Xiang Q, Chang AY, Garippa RJ, Merghoub T, Wolchok JD, Rosen N, Lowe SW, Scheinberg DA. Brea EJ, et al. Among authors: mondello p. Cancer Immunol Res. 2016 Nov;4(11):936-947. doi: 10.1158/2326-6066.CIR-16-0177. Epub 2016 Sep 28. Cancer Immunol Res. 2016. PMID: 27680026 Free PMC article.

7

Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.

Mondello P, Cuzzocrea S, Navarra M, Mian M. Mondello P, et al. Oncotarget. 2017 Mar 21;8(12):20394-20409. doi: 10.18632/oncotarget.14610. Oncotarget. 2017. PMID: 28099912 Free PMC article. Review.

8

An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules.

Dao T, Korontsvit T, Zakhaleva V, Jarvis C, Mondello P, Oh C, Scheinberg DA. Dao T, et al. Among authors: mondello p. Oncoimmunology. 2016 Dec 7;6(2):e1252895. doi: 10.1080/2162402X.2016.1252895. eCollection 2017. Oncoimmunology. 2016. PMID: 28344864 Free PMC article.

9

Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations.

Mondello P, Brea EJ, De Stanchina E, Toska E, Chang AY, Fennell M, Seshan V, Garippa R, Scheinberg DA, Baselga J, Wendel HG, Younes A. Mondello P, et al. JCI Insight. 2017 Mar 23;2(6):e90196. doi: 10.1172/jci.insight.90196. JCI Insight. 2017. PMID: 28352655 Free PMC article.

10

A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies.

Casey E, Bournazos S, Mo G, Mondello P, Tan KS, Ravetch JV, Scheinberg DA. Casey E, et al. Among authors: mondello p. Leukemia. 2018 Feb;32(2):547-549. doi: 10.1038/leu.2017.293. Epub 2017 Sep 19. Leukemia. 2018. PMID: 28924242 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters